Compounds > n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine
Page last updated: 2024-09-03

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and Nerve Degeneration

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with Nerve Degeneration in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kohda, Y; Kominami, E; Matsuda, M; Tonchev, AB; Tsuchiya, K; Yamashima, T; Yoshida, M; Zhao, L1

Other Studies

1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and Nerve Degeneration

ArticleYear
Primate neurons show different vulnerability to transient ischemia and response to cathepsin inhibition.
    Acta neuropathologica, 2002, Volume: 104, Issue:3

    Topics: Animals; Calpain; Cathepsin B; Cell Survival; Cysteine Proteinase Inhibitors; Dipeptides; Ischemic Attack, Transient; Leucine; Macaca; Necrosis; Nerve Degeneration; Neuroprotective Agents

2002